Search liu.se

Researchers have discovered how an ion channel in the brain’s neurons has a kind of ‘molecular memory’, which contributes to the formation and preservation of lifelong memories.

The Swedish Heart Lung Foundation has awarded 30 million to research projects at The Faculty of Medicine and Health Sciences. These grants will support a variety of projects aimed at heart, vascular, and lung diseases.

Sticky resin from conifers contains substances that could relieve or cure epilepsy. Researchers at Linköping University have synthesized and tested 71 substances known as resin acids, of which twelve are prime candidates for new medicines.

Technology, expertise, methods and initiatives can be coordinated more within and between higher education institutions. Linköping University is now one of four new sites in the Swedish research infrastructure SciLifeLab.

Neuroscientists obtain support from SciLifeLab when working to develop new drugs against epilepsy. The project is the first from Linköping University that has been accepted as a full program for the Drug Discovery and Development Platform (DDD).

New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy. A study published in the journal Epilepsia shows that several of the molecules have antiseizure effects.

Fredrik Elinder, professor in molecular neurobiology, has received the Onkel Adam Award for 2021 for his outstanding research in the Faculty of Medicine and Health Sciences at Linköping University.

Researchers at LiU have discovered a new mechanism by which substances can open a certain type of ion channel and in this way regulate nerve impulses. The discovery, published in the journal PNAS, may help in the development of future drugs.

LiU researchers have used high-throughput electrophysiology experiments with a borrowed machine to see how ion channels in cells are influenced by drugs. A new collaboration with the biotech industry.

Researchers at LiU have discovered a previously unknown molecular binding site that can influence electrical impulses in nerves. The discovery opens the possibility of designing new types of drugs against conditions such as epilepsy.